Global Multi Cancer Early Detection Market 2022 by Company, Regions, Type and Application, Forecast to 2028
Multi-cancer early detection (MCED) tests are tests that measure biological signals in body fluids that may be shed by cancer cells. These signals are also known as biomarkers or tumor markers. MCED tests are being developed to screen for cancers from more than one organ site at the same time.
The Multi Cancer Early Detection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Multi Cancer Early Detection market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.
The Multi Cancer Early Detection market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.
Hospitals occupied for % of the Multi Cancer Early Detection global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Liquid Biopsy segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Multi Cancer Early Detection include Grail, LLC (Illumina, Inc.), Exact Sciences Corporation., Foundation Medicine, Inc., AnchorDx and Guardant Health, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Key Features of This Report:
This report provides in-depth analysis of the global Multi Cancer Early Detection market, and provides market size and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year.
Main Multi Cancer Early Detection companies’ industry ranking, revenue, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This reports profiles key players in the global Multi Cancer Early Detection market based on the following parameters – headquarters, products portfolio, Multi Cancer Early Detection revenue and gross margin, recent developments.
Evaluation and forecast the Multi Cancer Early Detection market size, projected growth trends, and corresponding market share analysis by type, by application and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market segmentation
Multi Cancer Early Detection market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of revenue. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type (2017-2028; USD Million)
Chapter 1, to describe Multi Cancer Early Detection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Multi Cancer Early Detection, with revenue, gross margin and global market share of Multi Cancer Early Detection from 2019 to 2022.
Chapter 3, the Multi Cancer Early Detection competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Multi Cancer Early Detection market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Multi Cancer Early Detection research findings and conclusion, appendix and data source.
The Multi Cancer Early Detection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Multi Cancer Early Detection market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.
The Multi Cancer Early Detection market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.
Hospitals occupied for % of the Multi Cancer Early Detection global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Liquid Biopsy segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Multi Cancer Early Detection include Grail, LLC (Illumina, Inc.), Exact Sciences Corporation., Foundation Medicine, Inc., AnchorDx and Guardant Health, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Key Features of This Report:
This report provides in-depth analysis of the global Multi Cancer Early Detection market, and provides market size and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year.
Main Multi Cancer Early Detection companies’ industry ranking, revenue, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This reports profiles key players in the global Multi Cancer Early Detection market based on the following parameters – headquarters, products portfolio, Multi Cancer Early Detection revenue and gross margin, recent developments.
Evaluation and forecast the Multi Cancer Early Detection market size, projected growth trends, and corresponding market share analysis by type, by application and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market segmentation
Multi Cancer Early Detection market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of revenue. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type (2017-2028; USD Million)
- Liquid Biopsy
- Gene Panel, LDT & Others
- Hospitals
- Diagnostic Laboratories
- Others
- Grail, LLC (Illumina, Inc.)
- Exact Sciences Corporation.
- Foundation Medicine, Inc.
- AnchorDx
- Guardant Health, Inc.
- Burning Rock Biotech Limited
- GENECAST
- Laboratory for Advanced Medicine, Inc.
- Singlera Genomics Inc.
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Australia)
- South America (Brazil, Argentina, Colombia and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa and Rest of Middle East & Africa)
Chapter 1, to describe Multi Cancer Early Detection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Multi Cancer Early Detection, with revenue, gross margin and global market share of Multi Cancer Early Detection from 2019 to 2022.
Chapter 3, the Multi Cancer Early Detection competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Multi Cancer Early Detection market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Multi Cancer Early Detection research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Multi Cancer Early Detection
1.2 Classification of Multi Cancer Early Detection by Type
1.2.1 Overview: Global Multi Cancer Early Detection Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Multi Cancer Early Detection Revenue Market Share by Type in 2021
1.2.3 Liquid Biopsy
1.2.4 Gene Panel, LDT & Others
1.3 Global Multi Cancer Early Detection Market by Application
1.3.1 Overview: Global Multi Cancer Early Detection Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Global Multi Cancer Early Detection Market Size & Forecast
1.5 Global Multi Cancer Early Detection Market Size and Forecast by Region
1.5.1 Global Multi Cancer Early Detection Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Multi Cancer Early Detection Market Size by Region, (2017-2022)
1.5.3 North America Multi Cancer Early Detection Market Size and Prospect (2017-2028)
1.5.4 Europe Multi Cancer Early Detection Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Multi Cancer Early Detection Market Size and Prospect (2017-2028)
1.5.6 South America Multi Cancer Early Detection Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Multi Cancer Early Detection Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Multi Cancer Early Detection Market Drivers
1.6.2 Multi Cancer Early Detection Market Restraints
1.6.3 Multi Cancer Early Detection Trends Analysis
2 COMPANY PROFILES
2.1 Grail, LLC (Illumina, Inc.)
2.1.1 Grail, LLC (Illumina, Inc.) Details
2.1.2 Grail, LLC (Illumina, Inc.) Major Business
2.1.3 Grail, LLC (Illumina, Inc.) Multi Cancer Early Detection Product and Solutions
2.1.4 Grail, LLC (Illumina, Inc.) Multi Cancer Early Detection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Grail, LLC (Illumina, Inc.) Recent Developments and Future Plans
2.2 Exact Sciences Corporation.
2.2.1 Exact Sciences Corporation. Details
2.2.2 Exact Sciences Corporation. Major Business
2.2.3 Exact Sciences Corporation. Multi Cancer Early Detection Product and Solutions
2.2.4 Exact Sciences Corporation. Multi Cancer Early Detection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Exact Sciences Corporation. Recent Developments and Future Plans
2.3 Foundation Medicine, Inc.
2.3.1 Foundation Medicine, Inc. Details
2.3.2 Foundation Medicine, Inc. Major Business
2.3.3 Foundation Medicine, Inc. Multi Cancer Early Detection Product and Solutions
2.3.4 Foundation Medicine, Inc. Multi Cancer Early Detection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Foundation Medicine, Inc. Recent Developments and Future Plans
2.4 AnchorDx
2.4.1 AnchorDx Details
2.4.2 AnchorDx Major Business
2.4.3 AnchorDx Multi Cancer Early Detection Product and Solutions
2.4.4 AnchorDx Multi Cancer Early Detection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 AnchorDx Recent Developments and Future Plans
2.5 Guardant Health, Inc.
2.5.1 Guardant Health, Inc. Details
2.5.2 Guardant Health, Inc. Major Business
2.5.3 Guardant Health, Inc. Multi Cancer Early Detection Product and Solutions
2.5.4 Guardant Health, Inc. Multi Cancer Early Detection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Guardant Health, Inc. Recent Developments and Future Plans
2.6 Burning Rock Biotech Limited
2.6.1 Burning Rock Biotech Limited Details
2.6.2 Burning Rock Biotech Limited Major Business
2.6.3 Burning Rock Biotech Limited Multi Cancer Early Detection Product and Solutions
2.6.4 Burning Rock Biotech Limited Multi Cancer Early Detection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Burning Rock Biotech Limited Recent Developments and Future Plans
2.7 GENECAST
2.7.1 GENECAST Details
2.7.2 GENECAST Major Business
2.7.3 GENECAST Multi Cancer Early Detection Product and Solutions
2.7.4 GENECAST Multi Cancer Early Detection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 GENECAST Recent Developments and Future Plans
2.8 Laboratory for Advanced Medicine, Inc.
2.8.1 Laboratory for Advanced Medicine, Inc. Details
2.8.2 Laboratory for Advanced Medicine, Inc. Major Business
2.8.3 Laboratory for Advanced Medicine, Inc. Multi Cancer Early Detection Product and Solutions
2.8.4 Laboratory for Advanced Medicine, Inc. Multi Cancer Early Detection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Laboratory for Advanced Medicine, Inc. Recent Developments and Future Plans
2.9 Singlera Genomics Inc.
2.9.1 Singlera Genomics Inc. Details
2.9.2 Singlera Genomics Inc. Major Business
2.9.3 Singlera Genomics Inc. Multi Cancer Early Detection Product and Solutions
2.9.4 Singlera Genomics Inc. Multi Cancer Early Detection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Singlera Genomics Inc. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Multi Cancer Early Detection Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Multi Cancer Early Detection Players Market Share in 2021
3.2.2 Top 10 Multi Cancer Early Detection Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Multi Cancer Early Detection Players Head Office, Products and Services Provided
3.4 Multi Cancer Early Detection Mergers & Acquisitions
3.5 Multi Cancer Early Detection New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Multi Cancer Early Detection Revenue and Market Share by Type (2017-2022)
4.2 Global Multi Cancer Early Detection Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Multi Cancer Early Detection Revenue Market Share by Application (2017-2022)
5.2 Global Multi Cancer Early Detection Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Multi Cancer Early Detection Revenue by Type (2017-2028)
6.2 North America Multi Cancer Early Detection Revenue by Application (2017-2028)
6.3 North America Multi Cancer Early Detection Market Size by Country
6.3.1 North America Multi Cancer Early Detection Revenue by Country (2017-2028)
6.3.2 United States Multi Cancer Early Detection Market Size and Forecast (2017-2028)
6.3.3 Canada Multi Cancer Early Detection Market Size and Forecast (2017-2028)
6.3.4 Mexico Multi Cancer Early Detection Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Multi Cancer Early Detection Revenue by Type (2017-2028)
7.2 Europe Multi Cancer Early Detection Revenue by Application (2017-2028)
7.3 Europe Multi Cancer Early Detection Market Size by Country
7.3.1 Europe Multi Cancer Early Detection Revenue by Country (2017-2028)
7.3.2 Germany Multi Cancer Early Detection Market Size and Forecast (2017-2028)
7.3.3 France Multi Cancer Early Detection Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Multi Cancer Early Detection Market Size and Forecast (2017-2028)
7.3.5 Russia Multi Cancer Early Detection Market Size and Forecast (2017-2028)
7.3.6 Italy Multi Cancer Early Detection Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Multi Cancer Early Detection Revenue by Type (2017-2028)
8.2 Asia-Pacific Multi Cancer Early Detection Revenue by Application (2017-2028)
8.3 Asia-Pacific Multi Cancer Early Detection Market Size by Region
8.3.1 Asia-Pacific Multi Cancer Early Detection Revenue by Region (2017-2028)
8.3.2 China Multi Cancer Early Detection Market Size and Forecast (2017-2028)
8.3.3 Japan Multi Cancer Early Detection Market Size and Forecast (2017-2028)
8.3.4 South Korea Multi Cancer Early Detection Market Size and Forecast (2017-2028)
8.3.5 India Multi Cancer Early Detection Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Multi Cancer Early Detection Market Size and Forecast (2017-2028)
8.3.7 Australia Multi Cancer Early Detection Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Multi Cancer Early Detection Revenue by Type (2017-2028)
9.2 South America Multi Cancer Early Detection Revenue by Application (2017-2028)
9.3 South America Multi Cancer Early Detection Market Size by Country
9.3.1 South America Multi Cancer Early Detection Revenue by Country (2017-2028)
9.3.2 Brazil Multi Cancer Early Detection Market Size and Forecast (2017-2028)
9.3.3 Argentina Multi Cancer Early Detection Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Multi Cancer Early Detection Revenue by Type (2017-2028)
10.2 Middle East & Africa Multi Cancer Early Detection Revenue by Application (2017-2028)
10.3 Middle East & Africa Multi Cancer Early Detection Market Size by Country
10.3.1 Middle East & Africa Multi Cancer Early Detection Revenue by Country (2017-2028)
10.3.2 Turkey Multi Cancer Early Detection Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Multi Cancer Early Detection Market Size and Forecast (2017-2028)
10.3.4 UAE Multi Cancer Early Detection Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Multi Cancer Early Detection
1.2 Classification of Multi Cancer Early Detection by Type
1.2.1 Overview: Global Multi Cancer Early Detection Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Multi Cancer Early Detection Revenue Market Share by Type in 2021
1.2.3 Liquid Biopsy
1.2.4 Gene Panel, LDT & Others
1.3 Global Multi Cancer Early Detection Market by Application
1.3.1 Overview: Global Multi Cancer Early Detection Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Global Multi Cancer Early Detection Market Size & Forecast
1.5 Global Multi Cancer Early Detection Market Size and Forecast by Region
1.5.1 Global Multi Cancer Early Detection Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Multi Cancer Early Detection Market Size by Region, (2017-2022)
1.5.3 North America Multi Cancer Early Detection Market Size and Prospect (2017-2028)
1.5.4 Europe Multi Cancer Early Detection Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Multi Cancer Early Detection Market Size and Prospect (2017-2028)
1.5.6 South America Multi Cancer Early Detection Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Multi Cancer Early Detection Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Multi Cancer Early Detection Market Drivers
1.6.2 Multi Cancer Early Detection Market Restraints
1.6.3 Multi Cancer Early Detection Trends Analysis
2 COMPANY PROFILES
2.1 Grail, LLC (Illumina, Inc.)
2.1.1 Grail, LLC (Illumina, Inc.) Details
2.1.2 Grail, LLC (Illumina, Inc.) Major Business
2.1.3 Grail, LLC (Illumina, Inc.) Multi Cancer Early Detection Product and Solutions
2.1.4 Grail, LLC (Illumina, Inc.) Multi Cancer Early Detection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Grail, LLC (Illumina, Inc.) Recent Developments and Future Plans
2.2 Exact Sciences Corporation.
2.2.1 Exact Sciences Corporation. Details
2.2.2 Exact Sciences Corporation. Major Business
2.2.3 Exact Sciences Corporation. Multi Cancer Early Detection Product and Solutions
2.2.4 Exact Sciences Corporation. Multi Cancer Early Detection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Exact Sciences Corporation. Recent Developments and Future Plans
2.3 Foundation Medicine, Inc.
2.3.1 Foundation Medicine, Inc. Details
2.3.2 Foundation Medicine, Inc. Major Business
2.3.3 Foundation Medicine, Inc. Multi Cancer Early Detection Product and Solutions
2.3.4 Foundation Medicine, Inc. Multi Cancer Early Detection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Foundation Medicine, Inc. Recent Developments and Future Plans
2.4 AnchorDx
2.4.1 AnchorDx Details
2.4.2 AnchorDx Major Business
2.4.3 AnchorDx Multi Cancer Early Detection Product and Solutions
2.4.4 AnchorDx Multi Cancer Early Detection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 AnchorDx Recent Developments and Future Plans
2.5 Guardant Health, Inc.
2.5.1 Guardant Health, Inc. Details
2.5.2 Guardant Health, Inc. Major Business
2.5.3 Guardant Health, Inc. Multi Cancer Early Detection Product and Solutions
2.5.4 Guardant Health, Inc. Multi Cancer Early Detection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Guardant Health, Inc. Recent Developments and Future Plans
2.6 Burning Rock Biotech Limited
2.6.1 Burning Rock Biotech Limited Details
2.6.2 Burning Rock Biotech Limited Major Business
2.6.3 Burning Rock Biotech Limited Multi Cancer Early Detection Product and Solutions
2.6.4 Burning Rock Biotech Limited Multi Cancer Early Detection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Burning Rock Biotech Limited Recent Developments and Future Plans
2.7 GENECAST
2.7.1 GENECAST Details
2.7.2 GENECAST Major Business
2.7.3 GENECAST Multi Cancer Early Detection Product and Solutions
2.7.4 GENECAST Multi Cancer Early Detection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 GENECAST Recent Developments and Future Plans
2.8 Laboratory for Advanced Medicine, Inc.
2.8.1 Laboratory for Advanced Medicine, Inc. Details
2.8.2 Laboratory for Advanced Medicine, Inc. Major Business
2.8.3 Laboratory for Advanced Medicine, Inc. Multi Cancer Early Detection Product and Solutions
2.8.4 Laboratory for Advanced Medicine, Inc. Multi Cancer Early Detection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Laboratory for Advanced Medicine, Inc. Recent Developments and Future Plans
2.9 Singlera Genomics Inc.
2.9.1 Singlera Genomics Inc. Details
2.9.2 Singlera Genomics Inc. Major Business
2.9.3 Singlera Genomics Inc. Multi Cancer Early Detection Product and Solutions
2.9.4 Singlera Genomics Inc. Multi Cancer Early Detection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Singlera Genomics Inc. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Multi Cancer Early Detection Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Multi Cancer Early Detection Players Market Share in 2021
3.2.2 Top 10 Multi Cancer Early Detection Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Multi Cancer Early Detection Players Head Office, Products and Services Provided
3.4 Multi Cancer Early Detection Mergers & Acquisitions
3.5 Multi Cancer Early Detection New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Multi Cancer Early Detection Revenue and Market Share by Type (2017-2022)
4.2 Global Multi Cancer Early Detection Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Multi Cancer Early Detection Revenue Market Share by Application (2017-2022)
5.2 Global Multi Cancer Early Detection Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Multi Cancer Early Detection Revenue by Type (2017-2028)
6.2 North America Multi Cancer Early Detection Revenue by Application (2017-2028)
6.3 North America Multi Cancer Early Detection Market Size by Country
6.3.1 North America Multi Cancer Early Detection Revenue by Country (2017-2028)
6.3.2 United States Multi Cancer Early Detection Market Size and Forecast (2017-2028)
6.3.3 Canada Multi Cancer Early Detection Market Size and Forecast (2017-2028)
6.3.4 Mexico Multi Cancer Early Detection Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Multi Cancer Early Detection Revenue by Type (2017-2028)
7.2 Europe Multi Cancer Early Detection Revenue by Application (2017-2028)
7.3 Europe Multi Cancer Early Detection Market Size by Country
7.3.1 Europe Multi Cancer Early Detection Revenue by Country (2017-2028)
7.3.2 Germany Multi Cancer Early Detection Market Size and Forecast (2017-2028)
7.3.3 France Multi Cancer Early Detection Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Multi Cancer Early Detection Market Size and Forecast (2017-2028)
7.3.5 Russia Multi Cancer Early Detection Market Size and Forecast (2017-2028)
7.3.6 Italy Multi Cancer Early Detection Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Multi Cancer Early Detection Revenue by Type (2017-2028)
8.2 Asia-Pacific Multi Cancer Early Detection Revenue by Application (2017-2028)
8.3 Asia-Pacific Multi Cancer Early Detection Market Size by Region
8.3.1 Asia-Pacific Multi Cancer Early Detection Revenue by Region (2017-2028)
8.3.2 China Multi Cancer Early Detection Market Size and Forecast (2017-2028)
8.3.3 Japan Multi Cancer Early Detection Market Size and Forecast (2017-2028)
8.3.4 South Korea Multi Cancer Early Detection Market Size and Forecast (2017-2028)
8.3.5 India Multi Cancer Early Detection Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Multi Cancer Early Detection Market Size and Forecast (2017-2028)
8.3.7 Australia Multi Cancer Early Detection Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Multi Cancer Early Detection Revenue by Type (2017-2028)
9.2 South America Multi Cancer Early Detection Revenue by Application (2017-2028)
9.3 South America Multi Cancer Early Detection Market Size by Country
9.3.1 South America Multi Cancer Early Detection Revenue by Country (2017-2028)
9.3.2 Brazil Multi Cancer Early Detection Market Size and Forecast (2017-2028)
9.3.3 Argentina Multi Cancer Early Detection Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Multi Cancer Early Detection Revenue by Type (2017-2028)
10.2 Middle East & Africa Multi Cancer Early Detection Revenue by Application (2017-2028)
10.3 Middle East & Africa Multi Cancer Early Detection Market Size by Country
10.3.1 Middle East & Africa Multi Cancer Early Detection Revenue by Country (2017-2028)
10.3.2 Turkey Multi Cancer Early Detection Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Multi Cancer Early Detection Market Size and Forecast (2017-2028)
10.3.4 UAE Multi Cancer Early Detection Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. Global Multi Cancer Early Detection Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Multi Cancer Early Detection Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Multi Cancer Early Detection Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Multi Cancer Early Detection Revenue (USD Million) by Region (2017-2022)
Table 5. Global Multi Cancer Early Detection Revenue Market Share by Region (2023-2028)
Table 6. Grail, LLC (Illumina, Inc.) Corporate Information, Head Office, and Major Competitors
Table 7. Grail, LLC (Illumina, Inc.) Major Business
Table 8. Grail, LLC (Illumina, Inc.) Multi Cancer Early Detection Product and Solutions
Table 9. Grail, LLC (Illumina, Inc.) Multi Cancer Early Detection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Exact Sciences Corporation. Corporate Information, Head Office, and Major Competitors
Table 11. Exact Sciences Corporation. Major Business
Table 12. Exact Sciences Corporation. Multi Cancer Early Detection Product and Solutions
Table 13. Exact Sciences Corporation. Multi Cancer Early Detection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Foundation Medicine, Inc. Corporate Information, Head Office, and Major Competitors
Table 15. Foundation Medicine, Inc. Major Business
Table 16. Foundation Medicine, Inc. Multi Cancer Early Detection Product and Solutions
Table 17. Foundation Medicine, Inc. Multi Cancer Early Detection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. AnchorDx Corporate Information, Head Office, and Major Competitors
Table 19. AnchorDx Major Business
Table 20. AnchorDx Multi Cancer Early Detection Product and Solutions
Table 21. AnchorDx Multi Cancer Early Detection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Guardant Health, Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Guardant Health, Inc. Major Business
Table 24. Guardant Health, Inc. Multi Cancer Early Detection Product and Solutions
Table 25. Guardant Health, Inc. Multi Cancer Early Detection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Burning Rock Biotech Limited Corporate Information, Head Office, and Major Competitors
Table 27. Burning Rock Biotech Limited Major Business
Table 28. Burning Rock Biotech Limited Multi Cancer Early Detection Product and Solutions
Table 29. Burning Rock Biotech Limited Multi Cancer Early Detection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. GENECAST Corporate Information, Head Office, and Major Competitors
Table 31. GENECAST Major Business
Table 32. GENECAST Multi Cancer Early Detection Product and Solutions
Table 33. GENECAST Multi Cancer Early Detection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Laboratory for Advanced Medicine, Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Laboratory for Advanced Medicine, Inc. Major Business
Table 36. Laboratory for Advanced Medicine, Inc. Multi Cancer Early Detection Product and Solutions
Table 37. Laboratory for Advanced Medicine, Inc. Multi Cancer Early Detection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Singlera Genomics Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Singlera Genomics Inc. Major Business
Table 40. Singlera Genomics Inc. Multi Cancer Early Detection Product and Solutions
Table 41. Singlera Genomics Inc. Multi Cancer Early Detection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Global Multi Cancer Early Detection Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 43. Global Multi Cancer Early Detection Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 44. Breakdown of Multi Cancer Early Detection by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Multi Cancer Early Detection Players Head Office, Products and Services Provided
Table 46. Multi Cancer Early Detection Mergers & Acquisitions in the Past Five Years
Table 47. Multi Cancer Early Detection New Entrants and Expansion Plans
Table 48. Global Multi Cancer Early Detection Revenue (USD Million) by Type (2017-2022)
Table 49. Global Multi Cancer Early Detection Revenue Share by Type (2017-2022)
Table 50. Global Multi Cancer Early Detection Revenue Forecast by Type (2023-2028)
Table 51. Global Multi Cancer Early Detection Revenue by Application (2017-2022)
Table 52. Global Multi Cancer Early Detection Revenue Forecast by Application (2023-2028)
Table 53. North America Multi Cancer Early Detection Revenue by Type (2017-2022) & (USD Million)
Table 54. North America Multi Cancer Early Detection Revenue by Type (2023-2028) & (USD Million)
Table 55. North America Multi Cancer Early Detection Revenue by Application (2017-2022) & (USD Million)
Table 56. North America Multi Cancer Early Detection Revenue by Application (2023-2028) & (USD Million)
Table 57. North America Multi Cancer Early Detection Revenue by Country (2017-2022) & (USD Million)
Table 58. North America Multi Cancer Early Detection Revenue by Country (2023-2028) & (USD Million)
Table 59. Europe Multi Cancer Early Detection Revenue by Type (2017-2022) & (USD Million)
Table 60. Europe Multi Cancer Early Detection Revenue by Type (2023-2028) & (USD Million)
Table 61. Europe Multi Cancer Early Detection Revenue by Application (2017-2022) & (USD Million)
Table 62. Europe Multi Cancer Early Detection Revenue by Application (2023-2028) & (USD Million)
Table 63. Europe Multi Cancer Early Detection Revenue by Country (2017-2022) & (USD Million)
Table 64. Europe Multi Cancer Early Detection Revenue by Country (2023-2028) & (USD Million)
Table 65. Asia-Pacific Multi Cancer Early Detection Revenue by Type (2017-2022) & (USD Million)
Table 66. Asia-Pacific Multi Cancer Early Detection Revenue by Type (2023-2028) & (USD Million)
Table 67. Asia-Pacific Multi Cancer Early Detection Revenue by Application (2017-2022) & (USD Million)
Table 68. Asia-Pacific Multi Cancer Early Detection Revenue by Application (2023-2028) & (USD Million)
Table 69. Asia-Pacific Multi Cancer Early Detection Revenue by Region (2017-2022) & (USD Million)
Table 70. Asia-Pacific Multi Cancer Early Detection Revenue by Region (2023-2028) & (USD Million)
Table 71. South America Multi Cancer Early Detection Revenue by Type (2017-2022) & (USD Million)
Table 72. South America Multi Cancer Early Detection Revenue by Type (2023-2028) & (USD Million)
Table 73. South America Multi Cancer Early Detection Revenue by Application (2017-2022) & (USD Million)
Table 74. South America Multi Cancer Early Detection Revenue by Application (2023-2028) & (USD Million)
Table 75. South America Multi Cancer Early Detection Revenue by Country (2017-2022) & (USD Million)
Table 76. South America Multi Cancer Early Detection Revenue by Country (2023-2028) & (USD Million)
Table 77. Middle East & Africa Multi Cancer Early Detection Revenue by Type (2017-2022) & (USD Million)
Table 78. Middle East & Africa Multi Cancer Early Detection Revenue by Type (2023-2028) & (USD Million)
Table 79. Middle East & Africa Multi Cancer Early Detection Revenue by Application (2017-2022) & (USD Million)
Table 80. Middle East & Africa Multi Cancer Early Detection Revenue by Application (2023-2028) & (USD Million)
Table 81. Middle East & Africa Multi Cancer Early Detection Revenue by Country (2017-2022) & (USD Million)
Table 82. Middle East & Africa Multi Cancer Early Detection Revenue by Country (2023-2028) & (USD Million)
Table 1. Global Multi Cancer Early Detection Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Multi Cancer Early Detection Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Multi Cancer Early Detection Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Multi Cancer Early Detection Revenue (USD Million) by Region (2017-2022)
Table 5. Global Multi Cancer Early Detection Revenue Market Share by Region (2023-2028)
Table 6. Grail, LLC (Illumina, Inc.) Corporate Information, Head Office, and Major Competitors
Table 7. Grail, LLC (Illumina, Inc.) Major Business
Table 8. Grail, LLC (Illumina, Inc.) Multi Cancer Early Detection Product and Solutions
Table 9. Grail, LLC (Illumina, Inc.) Multi Cancer Early Detection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Exact Sciences Corporation. Corporate Information, Head Office, and Major Competitors
Table 11. Exact Sciences Corporation. Major Business
Table 12. Exact Sciences Corporation. Multi Cancer Early Detection Product and Solutions
Table 13. Exact Sciences Corporation. Multi Cancer Early Detection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Foundation Medicine, Inc. Corporate Information, Head Office, and Major Competitors
Table 15. Foundation Medicine, Inc. Major Business
Table 16. Foundation Medicine, Inc. Multi Cancer Early Detection Product and Solutions
Table 17. Foundation Medicine, Inc. Multi Cancer Early Detection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. AnchorDx Corporate Information, Head Office, and Major Competitors
Table 19. AnchorDx Major Business
Table 20. AnchorDx Multi Cancer Early Detection Product and Solutions
Table 21. AnchorDx Multi Cancer Early Detection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Guardant Health, Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Guardant Health, Inc. Major Business
Table 24. Guardant Health, Inc. Multi Cancer Early Detection Product and Solutions
Table 25. Guardant Health, Inc. Multi Cancer Early Detection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Burning Rock Biotech Limited Corporate Information, Head Office, and Major Competitors
Table 27. Burning Rock Biotech Limited Major Business
Table 28. Burning Rock Biotech Limited Multi Cancer Early Detection Product and Solutions
Table 29. Burning Rock Biotech Limited Multi Cancer Early Detection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. GENECAST Corporate Information, Head Office, and Major Competitors
Table 31. GENECAST Major Business
Table 32. GENECAST Multi Cancer Early Detection Product and Solutions
Table 33. GENECAST Multi Cancer Early Detection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Laboratory for Advanced Medicine, Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Laboratory for Advanced Medicine, Inc. Major Business
Table 36. Laboratory for Advanced Medicine, Inc. Multi Cancer Early Detection Product and Solutions
Table 37. Laboratory for Advanced Medicine, Inc. Multi Cancer Early Detection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Singlera Genomics Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Singlera Genomics Inc. Major Business
Table 40. Singlera Genomics Inc. Multi Cancer Early Detection Product and Solutions
Table 41. Singlera Genomics Inc. Multi Cancer Early Detection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Global Multi Cancer Early Detection Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 43. Global Multi Cancer Early Detection Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 44. Breakdown of Multi Cancer Early Detection by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Multi Cancer Early Detection Players Head Office, Products and Services Provided
Table 46. Multi Cancer Early Detection Mergers & Acquisitions in the Past Five Years
Table 47. Multi Cancer Early Detection New Entrants and Expansion Plans
Table 48. Global Multi Cancer Early Detection Revenue (USD Million) by Type (2017-2022)
Table 49. Global Multi Cancer Early Detection Revenue Share by Type (2017-2022)
Table 50. Global Multi Cancer Early Detection Revenue Forecast by Type (2023-2028)
Table 51. Global Multi Cancer Early Detection Revenue by Application (2017-2022)
Table 52. Global Multi Cancer Early Detection Revenue Forecast by Application (2023-2028)
Table 53. North America Multi Cancer Early Detection Revenue by Type (2017-2022) & (USD Million)
Table 54. North America Multi Cancer Early Detection Revenue by Type (2023-2028) & (USD Million)
Table 55. North America Multi Cancer Early Detection Revenue by Application (2017-2022) & (USD Million)
Table 56. North America Multi Cancer Early Detection Revenue by Application (2023-2028) & (USD Million)
Table 57. North America Multi Cancer Early Detection Revenue by Country (2017-2022) & (USD Million)
Table 58. North America Multi Cancer Early Detection Revenue by Country (2023-2028) & (USD Million)
Table 59. Europe Multi Cancer Early Detection Revenue by Type (2017-2022) & (USD Million)
Table 60. Europe Multi Cancer Early Detection Revenue by Type (2023-2028) & (USD Million)
Table 61. Europe Multi Cancer Early Detection Revenue by Application (2017-2022) & (USD Million)
Table 62. Europe Multi Cancer Early Detection Revenue by Application (2023-2028) & (USD Million)
Table 63. Europe Multi Cancer Early Detection Revenue by Country (2017-2022) & (USD Million)
Table 64. Europe Multi Cancer Early Detection Revenue by Country (2023-2028) & (USD Million)
Table 65. Asia-Pacific Multi Cancer Early Detection Revenue by Type (2017-2022) & (USD Million)
Table 66. Asia-Pacific Multi Cancer Early Detection Revenue by Type (2023-2028) & (USD Million)
Table 67. Asia-Pacific Multi Cancer Early Detection Revenue by Application (2017-2022) & (USD Million)
Table 68. Asia-Pacific Multi Cancer Early Detection Revenue by Application (2023-2028) & (USD Million)
Table 69. Asia-Pacific Multi Cancer Early Detection Revenue by Region (2017-2022) & (USD Million)
Table 70. Asia-Pacific Multi Cancer Early Detection Revenue by Region (2023-2028) & (USD Million)
Table 71. South America Multi Cancer Early Detection Revenue by Type (2017-2022) & (USD Million)
Table 72. South America Multi Cancer Early Detection Revenue by Type (2023-2028) & (USD Million)
Table 73. South America Multi Cancer Early Detection Revenue by Application (2017-2022) & (USD Million)
Table 74. South America Multi Cancer Early Detection Revenue by Application (2023-2028) & (USD Million)
Table 75. South America Multi Cancer Early Detection Revenue by Country (2017-2022) & (USD Million)
Table 76. South America Multi Cancer Early Detection Revenue by Country (2023-2028) & (USD Million)
Table 77. Middle East & Africa Multi Cancer Early Detection Revenue by Type (2017-2022) & (USD Million)
Table 78. Middle East & Africa Multi Cancer Early Detection Revenue by Type (2023-2028) & (USD Million)
Table 79. Middle East & Africa Multi Cancer Early Detection Revenue by Application (2017-2022) & (USD Million)
Table 80. Middle East & Africa Multi Cancer Early Detection Revenue by Application (2023-2028) & (USD Million)
Table 81. Middle East & Africa Multi Cancer Early Detection Revenue by Country (2017-2022) & (USD Million)
Table 82. Middle East & Africa Multi Cancer Early Detection Revenue by Country (2023-2028) & (USD Million)
LIST OF FIGURES
Figure 1. Multi Cancer Early Detection Picture
Figure 2. Global Multi Cancer Early Detection Revenue Market Share by Type in 2021
Figure 3. Liquid Biopsy
Figure 4. Gene Panel, LDT & Others
Figure 5. Multi Cancer Early Detection Revenue Market Share by Application in 2021
Figure 6. Hospitals Picture
Figure 7. Diagnostic Laboratories Picture
Figure 8. Others Picture
Figure 9. Global Multi Cancer Early Detection Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Multi Cancer Early Detection Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Multi Cancer Early Detection Revenue Market Share by Region (2017-2028)
Figure 12. Global Multi Cancer Early Detection Revenue Market Share by Region in 2021
Figure 13. North America Multi Cancer Early Detection Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Multi Cancer Early Detection Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Multi Cancer Early Detection Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Multi Cancer Early Detection Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Multi Cancer Early Detection Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Multi Cancer Early Detection Market Drivers
Figure 19. Multi Cancer Early Detection Market Restraints
Figure 20. Multi Cancer Early Detection Market Trends
Figure 21. Grail, LLC (Illumina, Inc.) Recent Developments and Future Plans
Figure 22. Exact Sciences Corporation. Recent Developments and Future Plans
Figure 23. Foundation Medicine, Inc. Recent Developments and Future Plans
Figure 24. AnchorDx Recent Developments and Future Plans
Figure 25. Guardant Health, Inc. Recent Developments and Future Plans
Figure 26. Burning Rock Biotech Limited Recent Developments and Future Plans
Figure 27. GENECAST Recent Developments and Future Plans
Figure 28. Laboratory for Advanced Medicine, Inc. Recent Developments and Future Plans
Figure 29. Singlera Genomics Inc. Recent Developments and Future Plans
Figure 30. Global Multi Cancer Early Detection Revenue Share by Players in 2021
Figure 31. Multi Cancer Early Detection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 32. Global Top 3 Players Multi Cancer Early Detection Revenue Market Share in 2021
Figure 33. Global Top 10 Players Multi Cancer Early Detection Revenue Market Share in 2021
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 35. Global Multi Cancer Early Detection Revenue Share by Type in 2021
Figure 36. Global Multi Cancer Early Detection Market Share Forecast by Type (2023-2028)
Figure 37. Global Multi Cancer Early Detection Revenue Share by Application in 2021
Figure 38. Global Multi Cancer Early Detection Market Share Forecast by Application (2023-2028)
Figure 39. North America Multi Cancer Early Detection Sales Market Share by Type (2017-2028)
Figure 40. North America Multi Cancer Early Detection Sales Market Share by Application (2017-2028)
Figure 41. North America Multi Cancer Early Detection Revenue Market Share by Country (2017-2028)
Figure 42. United States Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Multi Cancer Early Detection Sales Market Share by Type (2017-2028)
Figure 46. Europe Multi Cancer Early Detection Sales Market Share by Application (2017-2028)
Figure 47. Europe Multi Cancer Early Detection Revenue Market Share by Country (2017-2028)
Figure 48. Germany Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Multi Cancer Early Detection Sales Market Share by Type (2017-2028)
Figure 54. Asia-Pacific Multi Cancer Early Detection Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Multi Cancer Early Detection Revenue Market Share by Region (2017-2028)
Figure 56. China Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. South Korea Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Multi Cancer Early Detection Sales Market Share by Type (2017-2028)
Figure 63. South America Multi Cancer Early Detection Sales Market Share by Application (2017-2028)
Figure 64. South America Multi Cancer Early Detection Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East and Africa Multi Cancer Early Detection Sales Market Share by Type (2017-2028)
Figure 68. Middle East and Africa Multi Cancer Early Detection Sales Market Share by Application (2017-2028)
Figure 69. Middle East and Africa Multi Cancer Early Detection Revenue Market Share by Country (2017-2028)
Figure 70. Turkey Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Saudi Arabia Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. UAE Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Multi Cancer Early Detection Picture
Figure 2. Global Multi Cancer Early Detection Revenue Market Share by Type in 2021
Figure 3. Liquid Biopsy
Figure 4. Gene Panel, LDT & Others
Figure 5. Multi Cancer Early Detection Revenue Market Share by Application in 2021
Figure 6. Hospitals Picture
Figure 7. Diagnostic Laboratories Picture
Figure 8. Others Picture
Figure 9. Global Multi Cancer Early Detection Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Multi Cancer Early Detection Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Multi Cancer Early Detection Revenue Market Share by Region (2017-2028)
Figure 12. Global Multi Cancer Early Detection Revenue Market Share by Region in 2021
Figure 13. North America Multi Cancer Early Detection Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Multi Cancer Early Detection Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Multi Cancer Early Detection Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Multi Cancer Early Detection Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Multi Cancer Early Detection Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Multi Cancer Early Detection Market Drivers
Figure 19. Multi Cancer Early Detection Market Restraints
Figure 20. Multi Cancer Early Detection Market Trends
Figure 21. Grail, LLC (Illumina, Inc.) Recent Developments and Future Plans
Figure 22. Exact Sciences Corporation. Recent Developments and Future Plans
Figure 23. Foundation Medicine, Inc. Recent Developments and Future Plans
Figure 24. AnchorDx Recent Developments and Future Plans
Figure 25. Guardant Health, Inc. Recent Developments and Future Plans
Figure 26. Burning Rock Biotech Limited Recent Developments and Future Plans
Figure 27. GENECAST Recent Developments and Future Plans
Figure 28. Laboratory for Advanced Medicine, Inc. Recent Developments and Future Plans
Figure 29. Singlera Genomics Inc. Recent Developments and Future Plans
Figure 30. Global Multi Cancer Early Detection Revenue Share by Players in 2021
Figure 31. Multi Cancer Early Detection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 32. Global Top 3 Players Multi Cancer Early Detection Revenue Market Share in 2021
Figure 33. Global Top 10 Players Multi Cancer Early Detection Revenue Market Share in 2021
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 35. Global Multi Cancer Early Detection Revenue Share by Type in 2021
Figure 36. Global Multi Cancer Early Detection Market Share Forecast by Type (2023-2028)
Figure 37. Global Multi Cancer Early Detection Revenue Share by Application in 2021
Figure 38. Global Multi Cancer Early Detection Market Share Forecast by Application (2023-2028)
Figure 39. North America Multi Cancer Early Detection Sales Market Share by Type (2017-2028)
Figure 40. North America Multi Cancer Early Detection Sales Market Share by Application (2017-2028)
Figure 41. North America Multi Cancer Early Detection Revenue Market Share by Country (2017-2028)
Figure 42. United States Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Multi Cancer Early Detection Sales Market Share by Type (2017-2028)
Figure 46. Europe Multi Cancer Early Detection Sales Market Share by Application (2017-2028)
Figure 47. Europe Multi Cancer Early Detection Revenue Market Share by Country (2017-2028)
Figure 48. Germany Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Multi Cancer Early Detection Sales Market Share by Type (2017-2028)
Figure 54. Asia-Pacific Multi Cancer Early Detection Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Multi Cancer Early Detection Revenue Market Share by Region (2017-2028)
Figure 56. China Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. South Korea Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Multi Cancer Early Detection Sales Market Share by Type (2017-2028)
Figure 63. South America Multi Cancer Early Detection Sales Market Share by Application (2017-2028)
Figure 64. South America Multi Cancer Early Detection Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East and Africa Multi Cancer Early Detection Sales Market Share by Type (2017-2028)
Figure 68. Middle East and Africa Multi Cancer Early Detection Sales Market Share by Application (2017-2028)
Figure 69. Middle East and Africa Multi Cancer Early Detection Revenue Market Share by Country (2017-2028)
Figure 70. Turkey Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Saudi Arabia Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. UAE Multi Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source
